GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BrightPath Biotherapeutics Co Ltd (TSE:4594) » Definitions » DeferredTaxAndRevenue

BrightPath Biotherapeutics Co (TSE:4594) DeferredTaxAndRevenue : 円0.00 Mil (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is BrightPath Biotherapeutics Co DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

BrightPath Biotherapeutics Co's current deferred tax and revenue for the quarter that ended in Sep. 2024 was 円0.00 Mil.

BrightPath Biotherapeutics Co DeferredTaxAndRevenue Historical Data

The historical data trend for BrightPath Biotherapeutics Co's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BrightPath Biotherapeutics Co DeferredTaxAndRevenue Chart

BrightPath Biotherapeutics Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BrightPath Biotherapeutics Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

BrightPath Biotherapeutics Co DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of BrightPath Biotherapeutics Co's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


BrightPath Biotherapeutics Co Business Description

Traded in Other Exchanges
N/A
Address
2-2-4 Kojimachi, Kojimachi Central Building 7th Floor, Chiyoda-ku, Tokyo, JPN
BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.

BrightPath Biotherapeutics Co Headlines

No Headlines